Native Cardio, Inc.

About

Native Cardio, Inc. is a late-stage medical device company based in Naples, FL that develops minimally invasive solutions for postoperative atrial fibrillation (POAF). The company's Targeted Tissue Delivery System delivers precise, low-dose antiarrhythmic therapy and ultralow-energy cardioversion to restore normal heart rhythm without sedation or anesthesia. Native Cardio serves cardiac surgery centers, hospitals, and healthcare providers seeking cost-efficient alternatives to current POAF treatments.

Product

Value proposition

A late-stage medical device company delivering precise, low-dose therapy and painless cardioversion to transform cardiac care.

Target customers

cardiac surgery centers, hospitals, healthcare providers

Founders

• Joseph Pergolizzi — Co-founder and CEO
• Young D. Kim — Co-founder and Board Member

Products

Key features

Technologies

Target conditions

Care settings

Partnerships

Investors

News

• Management - NativeCardio, Inc. · 2025-06-13T00:00:00.000Z
• CardiaTec Biosciences – Cambridge Enterprise · 2025-04-22T07:00:39.000Z
• Heart disease is the world's biggest killer — this Cambridge Uni spinout is using AI to find new treatments | TechCrunch · 2024-09-10T04:00:00.000Z
• Press release: Ncardia launches Ncyte® Heart in a Box · 2025-01-27T12:01:54.000Z
• Chamber gets a $60M jolt to scale value-based cardiology care · 2026-02-04T00:00:00.000Z
• CardiaTec raises $6.5M Seed for cardiovascular drug discovery - Tech.eu · 2024-09-10T04:00:00.000Z

Browse related software

• Clinic software in FL
• Clinic software in Naples
• MedTech software
• Health AI software
• All clinic software companies A–Z

More links